THANK YOU FOR SUBSCRIBING
Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
EmsanaRx: Bringing Integrity and Accountability to PBM Industry
Greg Baker, CEO, EmsanaRx“We’re a for-profit, mission-driven Public Benefit Corporation (PBC) with an aim to drive transparency and quality of care while reducing unnecessary medical costs for millions of businesses and employees alike,” states Greg Baker, founder and CEO of EmsanaRx.
EmsanaRx strives to improve the health care experience and PBM industry practices with its clinical expertise, flexible customization and transparent pricing. The company uses a combination of state-of-the-art technology and consultative white-glove service to lower costs, improve health outcomes and generate measurable results through real-time client and patient-level reporting. In addition, EmsanaRx has employed Engagement Liaisons to manage the process from start to end proactively.
It makes a difference by eliminating the GPO layer and charging a fixed, pre-decided fee and offering a seamless onboarding process with contracts using simplified language. The company also provides its clients with full audit rights and data ownership, which helps maintain a digital trail of each transaction.
To further illustrate the efficiency of EmsanaRx’s PBM solutions is an instance where one of their first clients, a regional medical center, spent a significant amount of their funds on the pharmaceutical budget and was facing bankruptcy. They sought assistance to drive better decision-making to escape their dire financial situation. EmsanaRx handled the case in a white-glove service approach and allocated Engagement Liaisons in the process to ensure analysis of each drug individually. Following this, it replaced any high-cost drug with a similar low-cost variant while consulting with doctors and pharmacies in every decision to ascertain there was no member disruption. Over the course of 6months, using state-of-the-art technologies and dedicated Engagement Liaisons supervising every prescription request, EmsanaRx was able to significantly reduce the client’s pharmaceutical costs by 62.6 percent.
The PBM market is projected to grow to $740.05 billion globally by 2029 as per a Fortune Business Insights report. All the health insurers, employers, companies and other payers will need PBMs to help in the cost management of pharmacy costs more than ever. EmsanaRx envisions reshaping the PBM industry with a clinically-led working model of total transparency, clarity and ease. Its name reflects its mission- ‘Emsana’ is a combination of the word ‘em’ for ‘employer/employee’ and the word ‘Sana,’ which means health in Sanskrit and simple/straightforward in Arabic. EmsanaRx intends to continually build and improve PBM channels for their clients to provide better and more economical health care outcomes.
We’re a for-profit, mission-driven Public Benefit Corporation (PBC) with an aim to drive transparency and quality of care while reducing unnecessary medical costs for millions of businesses and employees alike
